Pre-Clinical Evaluation of a (213)Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication

BACKGROUND: Any strategy for curing HIV infection must include a method to eliminate viral-infected cells. Based on our earlier proof-of-principle results targeting HIV-1 infected cells with radiolabeled antibody (mAb) to gp41 viral antigen, we embarked on identifying a suitable candidate mAb for pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dadachova, Ekaterina, Kitchen, Scott G., Bristol, Gregory, Baldwin, Gayle Cocita, Revskaya, Ekaterina, Empig, Cyril, Thornton, George B., Gorny, Miroslaw K., Zolla-Pazner, Susan, Casadevall, Arturo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302885/
https://www.ncbi.nlm.nih.gov/pubmed/22427811
http://dx.doi.org/10.1371/journal.pone.0031866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302885/
https://www.ncbi.nlm.nih.gov/pubmed/22427811
http://dx.doi.org/10.1371/journal.pone.0031866

Ejemplares similares